PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
Analysis of 50 patients with advanced HPV16-positive cancers treated with the combination of PDS0101, PDS01ADC and an immune checkpoint inhibitor showed strong and broad immune activation, with ...
Hosted on MSN
SNAP funding expiration set to hit 40 million people
(The Hill) — More than 40 million low-income food stamp beneficiaries are expected to receive less help with grocery bills — or no help at all — in the coming days. The U.S. Department of Agriculture ...
Discover how AI-powered customer interactions can be revolutionized with mainframe data, offering real-time access and ...
The launch of the AI-focused z17 mainframe earlier this year has been a major success. Infrastructure is expected to drive 1.5 percentage points of revenue growth in 2025 for IBM. IBM boosted its ...
Leaders today are facing a crisis of employee engagement and trust in company leadership. According to Gallup, U.S. employee engagement dropped to 31% in 2024, the lowest level in a decade, with 17% ...
A quiet revolution is reshaping enterprise data engineering. Python developers are building production data pipelines in ...
Steven Lockey's position is funded by the Chair in Trust research partnership between the University of Melbourne and KPMG Australia. Nicole Gillespie receives funding from the Australian Research ...
How to Create a Timeline in Google Sheets for Projects & Planning Your email has been sent Learn how to create a timeline in Google Sheets fast: eligibility, setup, grouping, colors, templates, plus ...
Artificial intelligence (AI) is giving everyone, including children, the power to create terrifyingly realistic and misleading content. As police investigate another case of digitally altered explicit ...
1don MSN
PDS Biotech outlines trial protocol amendment for accelerated PFS endpoint in HPV16-positive cancer
Get key insights from PDS Biotech’s Q3 2025 earnings call, including regulatory updates for PDS0101 in HPV16+ cancer and financial highlights.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results